Bioqual Inc
OTC:BIOQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zhejiang Runyang New Material Technology Co Ltd
SZSE:300920
|
CN |
Bioqual Inc
Total Liabilities
Bioqual Inc
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bioqual Inc
OTC:BIOQ
|
Total Liabilities
$21m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
16%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Liabilities
$137.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
11%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Liabilities
$36.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Liabilities
$81.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Liabilities
$7B
|
CAGR 3-Years
18%
|
CAGR 5-Years
18%
|
CAGR 10-Years
16%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Liabilities
$9.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
17%
|
|
Bioqual Inc
Glance View
Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. The company is headquartered in Rockville, Maryland. The firm also performs in vitro contract research services. The company is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. The In vitro services include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation and other cell-based assays. The firm provides its services to the federal government, universities and the life science and pharmaceutical industries.
See Also
What is Bioqual Inc's Total Liabilities?
Total Liabilities
21m
USD
Based on the financial report for May 31, 2025, Bioqual Inc's Total Liabilities amounts to 21m USD.
What is Bioqual Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
16%
Over the last year, the Total Liabilities growth was 11%. The average annual Total Liabilities growth rates for Bioqual Inc have been -7% over the past three years , and 16% over the past ten years .
